Source: Healio Coverage
September 29, 2021
1 min read

Top in endocrinology: Menopause-related sleep disturbance, time-restricted eating

Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

A speaker at the North American Menopause Society Annual Meeting told attendees that menopause-related sleep fragmentation may negatively impact mood, metabolism and daytime wellbeing. It was the top story in endocrinology last week.

Another top story explored the potential benefits of time-restricted eating, which researchers said could help prevent heart disease and diabetes, among other cardiometabolic disorders.

Source: Adobe Stock

Read these and more top stories in endocrinology below:

Menopause-related sleep disturbances influence mood, metabolism

Menopause-related sleep fragmentation has downstream effects on mood, daytime wellbeing and metabolism, even when women meet recommended guidelines for normal sleep duration, according to a speaker. Read more.

Time-restricted eating may help prevent, manage many cardiometabolic diseases

Adopting a time-restricted eating schedule to align with a person’s circadian clock could help prevent diabetes, heart disease and other diseases, according to researchers. Read more.

Girls exposed to endocrine-disrupting chemical have higher glucose level as adults

Girls exposed to high levels of perfluorohexane sulfonate have a higher risk for dysregulated glucose metabolism during and after puberty, according to findings published in Environmental Health Perspectives. Read more.

Early weight loss may protect fertility for boys with obesity

Short-term weight loss may improve Leydig cell function and help protect future fertility for boys with obesity, according to data presented at the European Society for Pediatric Endocrinology virtual meeting. Read more.

More diabetes treatment adds life years, reduces costs in low-, middle-income nations

Increasing treatment and control of diabetes for people living in low- or middle-income countries could reduce risks for complications and, in turn, save health care dollars, according to findings from a microsimulation. Read more.